We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$1.29B
Cap. Flow
+$528M
Cap. Flow %
4.63%
Top 10 Hldgs %
25.25%
Holding
2,093
New
704
Increased
330
Reduced
366
Closed
687

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$75M
2
CVX icon
Chevron
CVX
+$59.9M
3
GEHC icon
GE HealthCare
GEHC
+$57.5M
4
APP icon
Applovin
APP
+$54.7M
5
OKLO
Oklo
OKLO
+$52.8M

Top Sells

Rank Stock Value
1
XEL icon
Xcel Energy
XEL
+$137M
2
META icon
Meta Platforms (Facebook)
META
+$61.8M
3
BDX icon
Becton Dickinson
BDX
+$59.9M
4
CRWV
CoreWeave
CRWV
+$57.1M
5
AAPL icon
Apple
AAPL
+$50.2M

Sector Composition

Rank Sector Weight
1 Healthcare 11.73%
2 Financials 9.81%
3 Utilities 8.63%
4 Technology 7.6%
5 Industrials 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSC icon
2026
PUT
WillScot Mobile Mini Holdings
WSC
$4.01B
-121,500
Closed -$3.37M
X
2027
DELISTED
US Steel
X
-92,323
Closed -$3.9M
XBI icon
2028
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.2B
-100,000
Closed -$8.11M
XBI icon
2029
State Street SPDR S&P Biotech ETF
XBI
$11.2B
-284,457
Closed -$23.1M
XENE icon
2030
Xenon Pharmaceuticals
XENE
$5.88B
-42,000
Closed -$1.41M
XLV icon
2031
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
-300,000
Closed -$43.8M
XOM icon
2032
ExxonMobil
XOM
$679B
-5,639
Closed -$603K
XP icon
2033
XP
XP
$8.53B
-193,259
Closed -$2.66M
XPER icon
2034
Xperi
XPER
$305M
-85,607
Closed -$661K
XPRO icon
2035
Expro Ltd
XPRO
$2.05B
-11,221
Closed -$112K
XRAY icon
2036
Dentsply Sirona
XRAY
$2.18B
-204,956
Closed -$3.06M
XRX icon
2037
Xerox
XRX
$381M
-227,596
Closed -$1.1M
YELP icon
2038
Yelp
YELP
$1.27B
-16,123
Closed -$597K
YEXT icon
2039
Yext
YEXT
$637M
-36,309
Closed -$224K
YORW icon
2040
York Water
YORW
$552M
-12,207
Closed -$423K
YOU icon
2041
Clear Secure
YOU
$4.46B
-240,922
Closed -$6.24M
ZBH icon
2042
Zimmer Biomet
ZBH
$19.3B
-206,329
Closed -$23.4M
ZGN icon
2043
Zegna
ZGN
$3.73B
-251,449
Closed -$1.86M
ZION icon
2044
Zions Bancorporation
ZION
$9.95B
-134,120
Closed -$6.69M
ZM icon
2045
Zoom
ZM
$31.5B
-87,973
Closed -$6.49M
ZVRA icon
2046
Zevra Therapeutics
ZVRA
$705M
-41,932
Closed -$314K
FLUT icon
2047
Flutter Entertainment
FLUT
$17.8B
-150,463
Closed -$33.3M
AS icon
2048
Amer Sports
AS
$19B
-208,580
Closed -$5.58M
ARQ icon
2049
Arq
ARQ
$100M
-10,924
Closed -$46K
DAY
2050
DELISTED
Dayforce
DAY
-12,297
Closed -$717K

Similar funds

Michael Gelband's Q2 2025 Portfolio in Review

As of Q2 2025, Michael Gelband held 2,093 positions worth $11.4B, up 13% from $10.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Michael Gelband deployed $528M of net new capital in Q2 2025, opening 704 new positions and adding to 330 existing holdings. Its largest new stake was Chevron: 424,949 shares worth $60.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Utilities.

On the sell side, the largest reduction was Xcel Energy, an estimated $137M trimmed.

  • Michael Gelband's largest Q2 2025 buy was Chevron: 424,949 shares worth $60.8M.
  • Michael Gelband added most to Paramount Global Class B in Q2 2025, an estimated $75M increase.
  • Michael Gelband's biggest Q2 2025 reduction was Xcel Energy, cutting an estimated $137M.
  • Michael Gelband fully exited Meta Platforms (Facebook) in Q2 2025, selling an estimated $61.8M.
  • Michael Gelband's ten largest holdings make up 25% of its $11.4B portfolio in Q2 2025.
  • Michael Gelband opened 704 new positions and closed 687 in Q2 2025.
  • Michael Gelband's portfolio value rose 13% quarter-over-quarter to $11.4B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.